Free Trial

Dogwood Therapeutics (DWTX) SEC Filings & 10K Form

$4.35
+0.19 (+4.57%)
(As of 10/31/2024 ET)

Recent Dogwood Therapeutics SEC Filings

DateFilerForm TypeView
10/30/2024
8:25 AM
Dogwood Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2024
3:29 PM
Dogwood Therapeutics, Inc. (Issuer)
Dogwood Therapeutics (Issuer)
Toh Kean Meng Melvin (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/17/2024
3:30 PM
Dogwood Therapeutics, Inc. (Issuer)
Dogwood Therapeutics (Issuer)
Yu Ying Choi Alan Abel (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/17/2024
3:29 PM
CK Life Sciences Intl Inc (0001297567) (Reporting)
Dogwood Therapeutics, Inc. (Issuer)
Dogwood Therapeutics (Issuer)
Sealbond Ltd (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/15/2024
3:19 PM
Sealbond Ltd (Filed by)
Virios Therapeutics, Inc. (Subject)
Dogwood Therapeutics (Subject)
Form SC 13D
10/07/2024
7:06 AM
Virios Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
Form DEFA14A
10/07/2024
7:02 AM
Virios Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2024
9:15 AM
Virios Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2024
8:30 AM
Virios Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/20/2024
8:15 AM
Virios Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/12/2024
8:15 AM
Virios Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/20/2024
8:28 AM
Virios Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2024
9:30 AM
Virios Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2024
7:01 AM
Virios Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2024
4:25 PM
Virios Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2024
4:26 PM
Virios Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
Form ARS
04/25/2024
3:33 PM
Virios Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
Form DEF 14A
03/01/2024
8:10 AM
Virios Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/29/2024
8:25 AM
Virios Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2024
11:43 AM
Gendreau Roger Michael (Reporting)
Virios Therapeutics, Inc. (Issuer)
Dogwood Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
11:47 AM
Grosswald Ralph (Reporting)
Virios Therapeutics, Inc. (Issuer)
Dogwood Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
11:51 AM
Virios Therapeutics, Inc. (Issuer)
Dogwood Therapeutics (Issuer)
Walsh Angela (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
11:54 AM
De La Rosa Abel (Reporting)
Virios Therapeutics, Inc. (Issuer)
Dogwood Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
11:40 AM
Duncan Gregory Scott (Reporting)
Virios Therapeutics, Inc. (Issuer)
Dogwood Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
3:21 PM
Virios Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
Form DEFA14A
02/13/2024
5:01 PM
Corday Brian David (Filed by)
Virios Therapeutics, Inc. (Subject)
Dogwood Therapeutics (Subject)
Form SC 13G/A
02/02/2024
3:31 PM
Virios Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
Form DEF 14A
02/02/2024
3:31 PM
Virios Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
Form DEF 14A
01/22/2024
8:33 AM
Virios Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
Form PRE 14A
01/03/2024
6:05 AM
Virios Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2023
8:10 AM
Virios Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/13/2023
6:20 AM
Virios Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2023
6:29 AM
Virios Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/02/2023
6:05 AM
Virios Therapeutics, Inc. (Filer)
Dogwood Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:DWTX) was last updated on 10/31/2024 by MarketBeat.com Staff
From Our Partners